{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:50Z","timestamp":1790905490681,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.07.039","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T14:36:57Z","timestamp":1154961417000},"page":"1-9","source":"Crossref","is-referenced-by-count":54,"title":["Reducing global disease burden of measles and rubella: Report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005"],"prefix":"10.1016","volume":"25","author":[{"given":"Claude P.","family":"Muller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques R.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henda","family":"Triki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Reef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.07.039_bib1","first-page":"55","article-title":"Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: burden of disease from CRS","volume":"75","author":"Cutts","year":"1997","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.07.039_bib2","unstructured":"World Health Organization. Guidelines for surveillance of congenital rubella syndrome and rubella. Field test version. WHO\/V&B\/99.22. Geneva: World Health Organization; 1999."},{"key":"10.1016\/j.vaccine.2006.07.039_bib3","unstructured":"World Health Organization. Preventing congenital rubella syndrome. Wkly Epidemiol Rec 2000;75:290\u20135."},{"key":"10.1016\/j.vaccine.2006.07.039_bib4","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1086\/497607","article-title":"Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee on research related to measles and rubella vaccines and vaccination, 2004","volume":"192","author":"Best","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib5","unstructured":"World Health Organization. Global measles and rubella laboratory network \u2013 update. Wkly Epidemiol Rec 2005;80:384\u20138."},{"key":"10.1016\/j.vaccine.2006.07.039_bib6","unstructured":"World Health Organization. The world health report 2005: make every mother and child count. Geneva: WHO."},{"key":"10.1016\/j.vaccine.2006.07.039_bib7","unstructured":"World Health Organization. Progress in reducing global measles deaths: 1999\u20132004. Wkly Epidemiol Rec 2006;81:90\u20134."},{"key":"10.1016\/j.vaccine.2006.07.039_bib8","unstructured":"WHO\/UNICEF. Joint statement on strategies to reduce measles mortality worldwide. Geneva: World Health Organization; 2001."},{"key":"10.1016\/j.vaccine.2006.07.039_bib9","unstructured":"WHO\/UNICEF. Measles: mortality reduction and regional elimination. Strategic plan 2001\u20132005. Geneva: World Health Organization; 2001. http:\/www.who.int\/vaccines-documents (accessed September 2005)."},{"key":"10.1016\/j.vaccine.2006.07.039_bib10","unstructured":"World Health Organization. www.who.int\/immunization monitoring\/diseases\/measles\/en\/index.html (accessed November 2005)."},{"issue":"9488","key":"10.1016\/j.vaccine.2006.07.039_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(05)67216-9","article-title":"Public-health impact of accelerated measles control in the WHO African Region","volume":"366","author":"Otten","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2006.07.039_bib12","first-page":"47","article-title":"Measles eradication: experience in the Am\u00e9ricas","volume":"76","author":"Quadros","year":"1998","journal-title":"Bull WHO"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.07.039_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/368032","article-title":"Progress toward measles eradication in the Region of the Am\u00e9ricas","volume":"187","author":"Quadros","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.07.039_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/377696","article-title":"Summary and conclusions: measles elimination meeting, 16\u201317 March 2000","volume":"189","author":"Katz","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib15","unstructured":"Preventable measles among US residents, 2001\u20132004. Centers for disease control and prevention (CDC). MMWR 2005;54(33):817\u201320."},{"key":"10.1016\/j.vaccine.2006.07.039_bib16","unstructured":"World Health Organization. Measles. Progress towards global control and regional elimination, 1998\u20131999. Wkly Epidemiol Rec 1999;74(50):429\u201334."},{"key":"10.1016\/j.vaccine.2006.07.039_bib17","unstructured":"CDC. Global Measles and Rubella Laboratory network, January 2004\u2013June 2005. MMWR 2005;54(43):1100\u20134."},{"key":"10.1016\/j.vaccine.2006.07.039_bib18","first-page":"185","article-title":"Disease eradication as a public health strategy: is measles next","volume":"50","author":"Olive","year":"1997","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.vaccine.2006.07.039_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0264-410X(99)00309-6","article-title":"Measles elimination: progress and challenges","volume":"17","author":"Cutts","year":"1999","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.07.039_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/368226","article-title":"The unfinished measles immunization agenda","volume":"187","author":"Strebel","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.07.039_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/381592","article-title":"The theory of measles elimination: implications for the design of elimination strategies","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1098\/rstb.2001.0856","article-title":"Catastrophes after crossing species barriers","volume":"356","author":"Osterhaus","year":"2001","journal-title":"Philos Trans R Soc Lond B"},{"key":"10.1016\/j.vaccine.2006.07.039_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","article-title":"Non-specific beneficial effect of measles immunization: analysis of mortality studies from developing countries","volume":"311","author":"Aaby","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2006.07.039_bib24","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/S0264-410X(03)00229-9","article-title":"The predicted impact of private sector MMR vaccination on the burden of congenital rubella syndrome","volume":"21","author":"Vynnycky","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.07.039_bib25","first-page":"69","article-title":"Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella","volume":"75","author":"Robertson","year":"1997","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.07.039_bib26","first-page":"264","article-title":"Economic analyses of rubella and rubella vaccines: a global review","volume":"80","author":"Hinman","year":"2002","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.07.039_bib27","first-page":"398","article-title":"Seroprevalence of rubella antibodies among pregnant females in Sri Lanka","volume":"34","author":"Palihawadana","year":"2003","journal-title":"Southeast Asian J Trop Med"},{"key":"10.1016\/j.vaccine.2006.07.039_bib28","first-page":"259","article-title":"Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India","volume":"82","author":"Vijayalakshmi","year":"2004","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.07.039_bib29","doi-asserted-by":"crossref","unstructured":"Best JM, Enders G. Laboratory diagnosis of rubella and congenital rubella. In: Banatvala JE, editor. Rubella Monograph. London: Elsevier; 2006, in press.","DOI":"10.1016\/S0168-7069(06)15003-X"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.039_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.inf.0000154366.26705.65","article-title":"Serologic diagnosis of congenital rubella: a cautionary tale","volume":"24","author":"Corcoran","year":"2005","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.07.039_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(05)17703-4","article-title":"Congenital rubella syndrome burden in Morocco: a rapid retrospective assessment","volume":"365","author":"Bloom","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.07.039_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2334-5-44","article-title":"Congenital rubella syndrome in Iran","volume":"5","author":"Sadighi","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.325.7356.147","article-title":"Interpretation of rubella serology in pregnancy \u2013 pitfalls and problems","volume":"325","author":"Best","year":"2002","journal-title":"Brit Med J"},{"issue":"10","key":"10.1016\/j.vaccine.2006.07.039_bib34","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JCM.42.10.4818-4820.2004","article-title":"Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection","volume":"42","author":"Mac\u00e9","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.07.039_bib35","unstructured":"Progress toward measles elimination\u2013region of the Americas, 2002\u20132003. MMWR 2004;53(14):304\u20136."},{"key":"10.1016\/j.vaccine.2006.07.039_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.287.4.464","article-title":"The changing epidemiology of rubella in the 1990s","volume":"287","author":"Reef","year":"2002","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.07.039_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/368036","article-title":"Limited diversity of measles field isolates after a national immunization day in Burkina Faso: progress from endemic to epidemic transmission?","volume":"187","author":"Mulders","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.07.039_bib38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s007050050045","article-title":"Genetic variability of measles viruses circulating in the Benelux","volume":"145","author":"Hanses","year":"2000","journal-title":"Arch Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2006.07.039_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/374607","article-title":"Genetic analysis of measles viruses isolated in the United States between 1989 and 2001: absence of an endemic genotype since 1994","volume":"189","author":"Rota","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib40","unstructured":"World Health Organization. Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemiol Rec 1998;73(35):265\u20139."},{"key":"10.1016\/j.vaccine.2006.07.039_bib41","unstructured":"World Health Organization. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec 2005;80:126\u201332."},{"key":"10.1016\/j.vaccine.2006.07.039_bib42","unstructured":"World Health Organization. Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemiol Rec 2003;78(27):229\u201332."},{"key":"10.1016\/j.vaccine.2006.07.039_bib43","unstructured":"World Health Organization. New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec 2005;80(40):347\u201351."},{"key":"10.1016\/j.vaccine.2006.07.039_bib44","series-title":"The molecular epidemiology of human viruses","first-page":"237","article-title":"Molecular epidemiology of measles virus","author":"Muller","year":"2002"},{"issue":"1","key":"10.1016\/j.vaccine.2006.07.039_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.40.1.5-9.2002","article-title":"Detection of measles virus-specific immunoglobulin M in dried venous blood samples by using a commercial enzyme immunoassay","volume":"40","author":"Riddell","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.039_bib46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jmv.20136","article-title":"Surveillance of measles in the Sudan using filter paper blood samples","volume":"73","author":"El Mubarak","year":"2004","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.039_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0732-8893(03)00166-4","article-title":"Whole blood samples as an alternative to serum for detection of immunity to measles virus by ELISA","volume":"47","author":"Chakravarti","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/rmv.1980010204","article-title":"Non-invasive virological diagnosis: are saliva and urine specimens adequate substitutes for blood?","volume":"1","author":"Mortimer","year":"1991","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2006.07.039_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0033-3506(01)00444-9","article-title":"A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children","volume":"115","author":"Vyse","year":"2001","journal-title":"Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2006.07.039_bib50","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/377103","article-title":"Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands","volume":"188","author":"van Binnendijk","year":"2003","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.039_bib51","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jmv.10144","article-title":"Detection of measles virus RNA in whole blood stored on filter paper","volume":"67","author":"Katz","year":"2002","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.07.039_bib52","first-page":"588","article-title":"Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia","volume":"79","author":"Nokes","year":"2001","journal-title":"Bull WHO"},{"issue":"4","key":"10.1016\/j.vaccine.2006.07.039_bib53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jmv.2100","article-title":"Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples","volume":"65","author":"Helfand","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2006.07.039_bib54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2005.06.017","article-title":"Detection of rubella immunoglobulin M from dried venous blood spots using a commercial enzyme immunoassay","volume":"53","author":"Karapanagiotidis","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2006.07.039_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jmv.1890400312","article-title":"Detection of measles, mumps and rubella antibodies in saliva using antibody capture radioimmunoassay","volume":"40","author":"Perry","year":"1993","journal-title":"J Med Virol"},{"issue":"7024","key":"10.1016\/j.vaccine.2006.07.039_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bmj.312.7024.161","article-title":"Congenital rubella in south India: diagnosis using saliva from infants with cataract","volume":"312","author":"Eckstein","year":"1996","journal-title":"Brit Med J"},{"key":"10.1016\/j.vaccine.2006.07.039_bib57","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-3156.1998.00227.x","article-title":"A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia","volume":"3","author":"Nokes","year":"1998","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2006.07.039_bib58","first-page":"76","article-title":"The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella","volume":"80","author":"Jin","year":"2002","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.07.039_bib59","unstructured":"World Health Organization. Progress in reducing global measles deaths: 1999\u20132003. Wkly Epidemiol Rec 2005;80:78\u201381."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T14:47:43Z","timestamp":1555771663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06008887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06008887"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.07.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}